Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 4689 - 4696 of 12015 results
Drugs, Biologics, and Regenerative Medicine in 2019: A Successful Year Ends with Promise of a More Challenging 2020
December 13, 2019| Blog| Viewpoint
Arbitration Agreement Enforcement Trends
December 13, 2019| Video| Viewpoint
Data Breach Class Actions Under the CCPA
December 13, 2019| Video| Viewpoint
Monthly TCPA Digest – December 2019
December 12, 2019| Article| Viewpoint
TCPA Legislative Update — After Much Negotiation, House Passes Consensus Robocall Legislation; Senate Vote Imminent
December 12, 2019| Article| Viewpoint
TCPA Regulatory Update — FCC Wakes from TCPA Hibernation with Orders Granting Two Petitions
December 12, 2019| Article| Viewpoint
TCPA Litigation Update — Courts See Through Scam Setup TCPA Suits
December 12, 2019| Article| Viewpoint
AB 5 - California’s New Independent Contractor Law
December 12, 2019| Video| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|